Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Tolerion Logo
Tolerion Growth Score
64
CB Rank
61943
Heat Score
69
Tolerion is a biotechnology company addressing the cause of autoimmune diseases through bio-therapeutic.
Founded
obfuscation
PrivateVenture - Series Unknown South San Francisco, California, United States1-10 tolerion.bio
Biotechnology
Medical
Therapeutics
Overview

Tolerion
Total Funding
obfuscation
Growth Score
64
Heat Score
69

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score64
-2 pts
in past quarter
Heat Score 69
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Tolerion

CB Rank
61943
Tolerion is a biotechnology company addressing the cause of autoimmune diseases through bio-therapeutic.
Founded
obfuscation
PrivateVenture - Series Unknown South San Francisco, California, United States1-10 tolerion.bio
Biotechnology
Medical
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation

Key People

Details

Legal Name Tolerion, Inc.
Operating Status Active
Company Type For Profit
Founders  Larry Steinman
About the Company

Tolerion is a biotechnology company addressing the cause of autoimmune diseases through bio-therapeutic. They use our novel antigen-specific immune tolerance induction platform to engineer product candidates that restore balance in autoimmune conditions in which self-antigens (or “autoantigens”) incite a destructive immune response.

Tolerion was

founded in 2001 and is headquartered in South San Francisco, California, USA.

Phone Number +415-795-5800
Contact Email info@tolerion.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Tolerion Platform
A platform designed to induce antigen-specific immune tolerance to treat autoimmune diseases by targeting the immune system's root cause.
TOL-3021
A tolerizing biologic in late-stage clinical development aimed at modifying disease progression in type 1 diabetes by reducing immune attack on insulin-producing cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Tolerion Logo
Venture Round - Tolerion
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$76.2KThis year, Tolerion is projected to spend $76.2K on IT, according to Aberdeen.

Active Website Tech Count

8Tolerion is actively using 8 technologies for its website, according to BuiltWith. These include DNSSEC, Global Site Tag, and  Amazon.
Sub-Organizations
Frequently Asked Questions

Where is Tolerion's headquarters? Tolerion is located in South San Francisco, California, United States.When was the last funding round for Tolerion? Tolerion closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Tolerion's competitors? Alternatives and possible competitors to Tolerion may include Cour Pharmaceuticals Development, TolerogenixX, and  Cyrus Biotechnology.How much funding has Tolerion raised to date? Tolerion has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|